Zomedica Corp. Net Income (Loss) Available to Common Stockholders, Basic
Zomedica Corp. (ZOMDF) reported Net Income (Loss) Available to Common Stockholders, Basic of -$491.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2023-11-13
- Zomedica Corp. net income (loss) available to common stockholders, basic for the quarter ending 2023-09-30 was -$491.00K.
- Zomedica Corp. net income (loss) available to common stockholders, basic for the quarter ending 2023-06-30 was -$5.25M.
- Zomedica Corp. net income (loss) available to common stockholders, basic for the quarter ending 2023-03-31 was -$6.38M.
- Zomedica Corp. net income (loss) available to common stockholders, basic for the quarter ending 2022-09-30 was -$5.00M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed |
|---|---|---|---|---|---|---|
| 2023-09-30 | -$491.00K 10-Q · filed 2023-11-13 | -$5.74M derived: sum of 2 quarters · filed 2023-11-13 | -$12.12M 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | -$5.25M 10-Q · filed 2023-08-10 | -$11.63M 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | -$6.38M 10-Q · filed 2023-05-11 | |||||
| 2022-09-30 | -$5.00M 10-Q · filed 2023-11-13 | -$10.27M derived: sum of 2 quarters · filed 2023-11-13 | -$14.21M 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | -$5.27M 10-Q · filed 2023-08-10 | -$9.21M 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | -$3.94M 10-Q · filed 2023-05-11 | |||||
| 2021-09-30 | -$6.35M 10-Q · filed 2022-11-14 | -$6.35M 10-Q · filed 2021-11-12 | -$11.06M derived: sum of 2 quarters · filed 2022-11-14 | -$47.13M 10-Q · filed 2022-11-14 | -$47.13M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$4.71M 10-Q · filed 2022-08-15 | -$4.71M 10-Q · filed 2021-08-11 | -$40.79M 10-Q · filed 2022-08-15 | -$40.79M 10-Q · filed 2021-08-11 | ||
| 2021-03-31 | -$36.08M 10-Q · filed 2022-05-10 | -$36.08M 10-Q · filed 2021-05-12 | ||||
| 2020-09-30 | -$4.98M 10-Q · filed 2021-11-12 | -$10.29M derived: sum of 2 quarters · filed 2021-11-12 | -$12.74M 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | -$5.31M 10-Q · filed 2021-08-11 | -$7.76M 10-Q · filed 2021-08-11 | ||||
| 2020-03-31 | -$2.45M 10-Q · filed 2021-05-12 |